Connection

IVAN ROSAS to Lung Neoplasms

This is a "connection" page, showing publications IVAN ROSAS has written about Lung Neoplasms.
Connection Strength

0.660
  1. Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness. Am J Respir Cell Mol Biol. 2019 06; 60(6):659-666.
    View in: PubMed
    Score: 0.312
  2. Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion. J Bras Pneumol. 2023; 49(2):e20220356.
    View in: PubMed
    Score: 0.102
  3. Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells. Chest. 2019 12; 156(6):1137-1148.
    View in: PubMed
    Score: 0.078
  4. Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study. Eur Respir J. 2015 Sep; 46(3):783-94.
    View in: PubMed
    Score: 0.059
  5. Prevalence and outcome of lung cancer in lung transplant recipients. Respir Med. 2015 Mar; 109(3):427-33.
    View in: PubMed
    Score: 0.057
  6. Telomeres in lung disease. Transl Res. 2013 Dec; 162(6):343-52.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.